N onmalignant asbestos-related disease continues to be a major public health and litigation challenge. 1 The risk of asbestosis developing increases with time since first exposure and duration of exposure. Frequently, the exposure history obtained from workers has been shown not to correlate with the actual quantity of asbestos fibers in the lung. 2, 3 Asbestos bodies (AB) are inhaled asbestos fibers that have been coated with hemosiderin by alveolar macrophages. AB in BAL may be reliable markers of asbestos exposure, and can be present as early as 10 months after exposure. Previous studies 4 -6 showed a significant correlation between the concentration of asbestos bodies in BAL fluid and in lung tissue. BAL is easy to perform and is more accurate than sputum examination in detecting AB in the alveolar space, although sputum evaluation has correlated with occupational exposure in heavily exposed retired asbestos factory workers. 7, 8 De Vuyst and colleagues 2, 9 reported that the concentration of AB in BAL correlated with degree of asbestos exposure.
The objective of our study was to evaluate the clinical utility of AB in BAL cells. We hypothesized that in subjects with asbestos exposure, the presence of AB in the BAL cytocentrifuge slide would correlate with radiologic and clinical findings of asbestosrelated lung disease. Our results showed that AB were present more frequently in asbestos-exposed subjects than in a matched control population. Moreover, among the subjects with a history of asbestos exposure, the presence of AB in the BAL specimen correlated significantly with respiratory symptoms, parenchymal disease on high-resolution CT (HRCT) scans, and reduced pulmonary function test (PFT) results.
Materials and Methods

Study Population
Asbestos-exposed subjects were recruited from Consolidated Edison, a local electric utility company in New York City. Subjects were screened using the American Thoracic Society respiratory symptoms questionnaire, and detailed occupational exposure histories. Chest radiographs, HRCT scans, and PFTs were performed in every subject with methods and predicted values for PFTs as previously described. 10 Normal volunteers were nonsmokers and had normal chest radiography and spirometry findings.
BAL
Fiberoptic bronchoscopy was performed as previously described. 10 The lavage fluid was pooled and strained through one layer of sterile gauze to remove clumps of mucous, and a cell count was obtained. A cytocentrifuge slide was made (Shandon Instruments; Pittsburgh, PA) and stained with Diff-Quik (Dade Behring; Deerfield, IL) for cell differential. Five hundred cells were counted for the differential.
Microscopic Evaluation of BAL Slides
BAL cytocentrifuge slides were randomly selected from 30 asbestos-exposed subjects as described above. BAL slides were also randomly selected from 30 matched normal volunteer BAL samples. A total of 60 slides were reviewed by two pulmonologists. The slides were blinded and scanned carefully with a 40 ϫ power light microscope. All microscopic fields were evaluated. Asbestos bodies were counted (typical AB are shown in Fig 1) . AB were counted by the first reader and confirmed by the second reader.
Statistical Analysis
Data were expressed as mean Ϯ SEM; p Ͻ 0.05 was conventionally used for significance testing. The Student two-tailed t test and Wilcoxon tests were used for statistical evaluation (SPSS; Chicago, IL).
Results
Presence of Asbestos Bodies in BAL
AB were found more frequently in subjects with a history of asbestos exposure compared to normal volunteers (33% vs 0%, p Ͻ 0.05). The average number of AB seen in the AB-positive group was 2.7 per slide (range, 1 to 11 per slide).
Demographic Data of Study Populations
The average ages of asbestos-exposed workers and normal volunteers were 55 years and 34 years, respectively. All asbestos-exposed subjects and 83% (25 of 30 subjects) of normal volunteers were male. Asbestos-exposed workers were classified into two groups: group 1 consisted of 10 subjects who had AB present in their BAL (AB-positive group), and group 2 had 19 subjects who did not have AB in their BAL (AB-negative group). Data were not available on one individual, and all were Con-Edison workers. Demographic data and smoking history were not significantly different between AB-positive and AB-negative subjects (Table 1) .
Asbestos Exposure History
Asbestos exposure histories (duration of exposure, time since the onset of exposure, and time since last exposure) were not significantly different between groups 1 and 2 ( Table 1) . Ongoing exposure was reported by 70% of AB-positive subjects, and 53% of AB-negative subjects. Occupational histories were similar in both groups: most were asbestos insulators, boiler makers, pipe fitters, and construction workers. Other occupations reported were shipyard workers and mechanics. Interestingly, most workers reported intensity of degrees of exposure ranging from severe to moderate in both groups. Only a minority reported wearing a protective particulate mask during work. 
Respiratory Symptoms
More AB-positive individuals reported respiratory symptoms than AB-negative subjects, especially cough and sputum production (p Ͻ 0.05; Table 2 ). Dyspnea was reported equally in both groups. More subjects in the AB-positive group had a history of COPD (30% vs 16%). None of the subjects were using a bronchodilator. One subject in the AB-negative group had a history of benign asbestos-related pleural effusion, which had resolved 3 years prior to the study.
BAL Fluid
BAL fluid data, including recovered volume and total cell count, were not significantly different between the two groups (Table 3) . In both groups, there was an increased number of total cells per milliliter compared to normal volunteers (208 ϫ 10 3 /mL) lavaged by the same methods. 11 The BAL of AB-positive subjects showed a significant increase in neutrophils and eosinophils (p Ͻ 0.05) indicating more alveolitis. One subject in each group had BAL with Ͼ 25% lymphocytes, and none had BAL with Ͼ 7% neutrophils. Multinucleate giant cells were seen in 3 of 10 subjects (30%) in the AB-positive group, and 5 of 19 subjects (26%) in the AB-negative group.
Chest Radiographs and HRCT Scans
Two AB-positive subjects had irregular opacities on their chest radiographs Ն 1/1. The incidence of pleural plaques and diffuse pleural thickening was not significantly different between the two groups on the plain chest radiographs. The HRCT scan is more sensitive than the chest radiograph for the detection of parenchymal abnormalities; in this regard, we found more interstitial changes in each group than on chest radiographs (Table 4 ). The HRCT scan of AB-positive subjects revealed a higher prevalence of parenchymal abnormalities compared to AB-negative subjects (70% vs 25%, p Ͻ 0.05; Table 4 ). Moreover, the degree of parenchymal abnormality was more severe in the AB-positive group than the AB-negative group, eg, pulmonary fibrosis (40% vs 0%, p Ͻ 0.01). Mild emphysematous changes were seen in two subjects in the AB-negative group, and none of the AB-positive subjects. 
PFTs
The AB-positive subjects had significantly reduced FEV 1 and diffusion capacity of the lung for carbon monoxide (Dlco) [p Ͻ 0.05], compared to the ABnegative subjects (Fig 2) . PFT interpretations in AB-positive subjects were obstructive airway dysfunction (60%) and normal (40%); in AB-negative subjects, obstructive airway dysfunction (63%), restrictive dysfunction (10%), and normal (27%).
Discussion
Although the presence of AB in BAL fluid confirms asbestos exposure, its clinical utility has so far not been proven. De Vuyst and colleagues 6 reported that the higher AB count in BAL was associated with asbestosis, whereas other studies 3, 12 showed that the concentration of AB in BAL was not associated with radiographic or physiologic abnormalities. Nevertheless, detection of AB in the lung is still the "gold standard" for asbestos exposure, and BAL remains the most sensitive way detect AB without open-lung biopsy. The detection of 1 AB/mL of BAL fluid represents approximately 1,000 to 3,000 AB/g dry lung tissue, 4 and the AB concentration in BAL had a good correlation to the content of AB in lung tissue up to 10,000/g dry lung tissue. 5 Therefore, it is logical to hypothesize that the presence of AB in BAL fluid, which implies significant asbestos exposure, correlates with clinical presentation. We used cytospin slides to count AB, which can be done retrospectively. In this study population from New York City, we found AB in one third of BAL cytospin slides from asbestos-exposed subjects, and none on cytospin slides from normal volunteers. Our results indicate that in subjects with a history of asbestos exposure, the presence of asbestos bodies on BAL slides was associated higher prevalence of respiratory symptoms and parenchymal abnormalities on HRCT scan, and reduced PFT test results. Our findings support the clinical utility of AB in BAL cytospin slides as an indicator for asbestos-related lung disease in a high-risk population.
We used the cytocentrifuge technique to process BAL slides because it is simple and can be performed in every laboratory. A previous study 13 using cytocentrifuge slides found AB in BAL of all five subjects with asbestos exposure. However, cytocentrifuge slides have been used less frequently in the detection and quantification of AB in BAL fluid because it has lower sensitivity when the level is Ͻ 10 AB/mL. 6 De Vuyst and members of a European Respiratory Society group 9 recommended the use of a membrane filter and light microscopy in counting the number of fibers in 20 mL of BAL fluid after they have been digested with sodium hypochlorite. The concentration that was considered significant by this technique was 1 AB/mL BAL, or 1 AB per 10 6 cells. 4, 6, 14 Using the membrane filter technique and 20 mL, one sample is approximately 7 to 10 ϫ 10 6 cells, whereas a cytospin slide is made with 50 to 100 ϫ 10 3 cells resulting in a reduced sensitivity of this technique in individuals with Ͻ 1 AB/mL. In a large series of 563 patients, those with asbestosis had a log mean 120 AB/mL, pleural plaques 5 AB/mL, asbestos exposed with a normal chest radiograph 4 AB/mL, and malignant mesothelioma or lung cancer 8 AB/mL. 6 Of 49 patients with Ͼ 100 AB/mL, 30 had asbestosis, 8 had pleural plaques, 13 had mesothelioma or lung cancer, and 3 were only exposed (including 2 subjects who had worked in a brake lining factory). Asbestosis patients consistently have two to five orders of magnitude more AB per milliliter than subjects with pleural plaque. Using optical electron microscopy in 31 individuals (24 asbestos exposed, 7 normal subjects), there were 28 ϫ 10 3 fibers (asbestos exposed) vs 1 ϫ 10 3 (normal subjects) for chrysotile or 1 fiber per 35 cells, and 4.7 ϫ 10 3 vs 0.3 ϫ 10 3 for amosite or 1 fiber per 215 cells. 15 Subjects with long-term exposure have higher concentrations of fibers than those with more recent exposure, probably because of higher workplace exposures in the past. Comparisons of asbestos fibers to asbestos bodies in BAL fluid in 108 asbestos-exposed workers revealed 3.2 ϫ 10 3 fibers vs 32 asbestos bodies; there was a 2:1 ratio of chrysotile to amosite fibers. 16 The AB-positive subjects had significantly increased neutrophils and eosinophils typical of an asbestos-induced alveolitis previously described by Robinson et al and us. 11, 17, 18 This is an important finding since we also found that AB-positive subjects acquired more parenchymal disease and had reduced Dlco. The presence of AB in the alveolar space indicates a high fiber burden in lung tissue, which serves as a continuous stimulus for the inflammation cascade leading to the development of interstitial lung disease. 19 Multinucleate giant cells are increased in asbestos-exposed subjects, and are a marker of ongoing phagocytosis. 18 We found multinucleate giant cells in 30% and 26% of BAL in AB-positive and AB-negative groups, respectively, consistent with history of ongoing exposure to asbestos reported by a majority of the subjects in both groups.
Most of our subjects had a history of cigarette smoking, and approximately 20% were active smokers. The high percentage of smokers might contribute to the numbers with COPD. Churg and Stevens 20 reported that smokers retained a higher numbers of asbestos fibers in the airway mucosa, and this may contribute to the pathogenesis of obstructive airway disease (OAD). The AB-positive subjects reported more respiratory symptoms, mostly chronic cough and productive phlegm, suggestive of airway disease. The FEV 1 was significantly lower in the AB-positive group, indicating OAD. In addition, the Dlco was significantly reduced in the AB-positive individuals consistent with asbestosis or parenchymal destruction in the presence of OAD.
The HRCT scans were consistent with a picture of parenchymal fibrosis. Animal studies 21, 22 in sheep and guinea pigs exposed to asbestos showed that the animals acquired peribronchial fibrosis, airway narrowing, and air trapping, independent of cigarette smoke exposure. Churg and colleagues 23 termed the condition mineral-dust airway disease, which described small airway dysfunction in nonsmoking asbestos-exposed workers. Griffith et al 24 performed PFTs and BAL in 30 nonsmoking asbestos and mixed dust-exposed workers and found that their FEV 1 and forced expiratory flow, midexpiratory range were significantly lower than nonexposed nonsmokers. However, the lung fiber burden and evidence of alveolitis in BAL did not correlate with the presence of airflow obstruction, suggesting that OAD was the result of an irritant response rather than fiber retention. Asbestos-exposed insulators Ն 20 years who were nonsmokers, or ex-smokers Ն 5 years and with radiographs greater than or equal to International Labour Organization category 1/0 had increased rates of FVC and FEV 1 decline. 25 Therefore, subjects with AB in their BAL may need to be followed up closely. We also reported that the HRCT score was associated with impaired physiology, reduced Dlco, and alveolitis. 10 In our current study, the HRCT scan detected additional interstitial changes that were not seen on chest radiographs in five subjects in each group. The HCRT scan also revealed significantly more parenchymal disease in the AB-positive group.
In asbestos-exposed subjects, the presence of AB in BAL cytospin slides should be viewed as a clinically important finding, and their HRCT scans should be reviewed carefully for evidence of interstitial lung disease. Pleural disease and asbestos exposure history were not different between the two groups. In addition, the diagnosis of asbestosis would be corroborated by finding one or more asbestos bodies on the cytospin slide from an individual with fibrosis on the CT scan accompanied by a history of asbestos exposure.
